Document Classification

Section Type: RESULTS

Text: Rosiglitazone, but not metformin, treatment increased expression of genes involved in triacylglycerol storage [e. g. stearyl-CoA desaturase (3. 2-fold), CD36 (1. 8-fold)], structural genes [e. g. alpha-1 type-1 procollagen (1. 7-fold) and GLUT4 (1. 5-fold)], and decreased expression of inflammation-related genes [e. g. IL-6 (0. 6-fold), chemokine (C-C motif) ligand 3 (0. 4-fold)], 11beta-hydroxysteroid dehydrogenase 1 (0. 6-fold), and resistin (0. 3-fold) (all P < 0. 05).